Enhanced SARS-CoV-2 neutralization by dimeric IgA
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes
coronavirus disease 2019 (COVID-19), primarily infects cells at mucosal surfaces. Serum …
coronavirus disease 2019 (COVID-19), primarily infects cells at mucosal surfaces. Serum …
Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis
Results All subjects in the control group developed an antibody response compared with
96%(54 of 56) positive responders in the dialysis group. The IgG levels in the dialysis group …
96%(54 of 56) positive responders in the dialysis group. The IgG levels in the dialysis group …
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is
central to long-term control of the current pandemic. Despite our rapidly advancing …
central to long-term control of the current pandemic. Despite our rapidly advancing …
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
H Rincon-Arevalo, M Choi, AL Stefanski, F Halleck… - Science …, 2021 - science.org
Patients with kidney failure are at increased risk of SARS-CoV-2 infection, making effective
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national …
K Maneikis, K Šablauskas, U Ringelevičiūtė… - The Lancet …, 2021 - thelancet.com
Background Haematological malignancies and their treatments are likely to affect SARS-
CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in …
CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in …
[HTML][HTML] Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
The evolution of SARS-CoV-2 could impair recognition of the virus by human antibody-
mediated immunity. To facilitate prospective surveillance for such evolution, we map how …
mediated immunity. To facilitate prospective surveillance for such evolution, we map how …
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
Immune protection following either vaccination or infection with SARS-CoV-2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health …
decrease over time. We designed a retrospective study, conducted at Leumit Health …
Association of SARS-CoV-2 seropositive antibody test with risk of future infection
RA Harvey, JA Rassen, CA Kabelac… - JAMA internal …, 2021 - jamanetwork.com
Importance Understanding the effect of serum antibodies to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) on susceptibility to infection is important for …
syndrome coronavirus 2 (SARS-CoV-2) on susceptibility to infection is important for …
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Background Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting
risk of reinfection and durability of vaccine protection. Methods This is a prospective …
risk of reinfection and durability of vaccine protection. Methods This is a prospective …
SARS-CoV-2-specific T cells in infection and vaccination
During viral infections, antibodies and T cells act together to prevent pathogen spread and
remove virus-infected cells. Virus-specific adaptive immunity can, however, also trigger …
remove virus-infected cells. Virus-specific adaptive immunity can, however, also trigger …